Glaukos Corp
NYSE:GKOS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.67
161.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
GKOS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 113.43 USD,
Glaukos Corp
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Glaukos Corp
GKOS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether GKOS usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Glaukos Corp.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Glaukos Corp
Balance Sheet Decomposition
Glaukos Corp
| Current Assets | 454.8m |
| Cash & Short-Term Investments | 273.7m |
| Receivables | 98.7m |
| Other Current Assets | 82.4m |
| Non-Current Assets | 544.6m |
| PP&E | 182.5m |
| Intangibles | 330.8m |
| Other Non-Current Assets | 31.3m |
| Current Liabilities | 87.5m |
| Accounts Payable | 19.9m |
| Accrued Liabilities | 67.6m |
| Non-Current Liabilities | 142.3m |
| Long-Term Debt | 68.5m |
| Other Non-Current Liabilities | 73.9m |
Free Cash Flow Analysis
Glaukos Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Glaukos Corp
|
Revenue
|
469.8m
USD
|
|
Cost of Revenue
|
-108.7m
USD
|
|
Gross Profit
|
361.1m
USD
|
|
Operating Expenses
|
-449.5m
USD
|
|
Operating Income
|
-88.4m
USD
|
|
Other Expenses
|
784k
USD
|
|
Net Income
|
-87.6m
USD
|
GKOS Profitability Score
Profitability Due Diligence
Glaukos Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Glaukos Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
GKOS Solvency Score
Solvency Due Diligence
Glaukos Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Glaukos Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GKOS Price Targets Summary
Glaukos Corp
According to Wall Street analysts, the average 1-year price target for
GKOS
is 126.19 USD
with a low forecast of 72.72 USD and a high forecast of 173.25 USD.
Dividends
Current shareholder yield for
GKOS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GKOS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 113.43 USD,
Glaukos Corp
is
hidden
.